Medipharm Labs Corp T.LABS

Today from the Tilray side...all quiet about the settlement

[subaru1i]

but they did announce this, see below.  It's this kind of news from Tilray that tells me real medical applications, ie pharma is not their strategy.  B2C, business to consumer in the CPG (consumer packaged goods) segment.   Tilray might be thinking down the road when legal at the U.S. Fed level for recreational that an opportunity exists to make and sell cannabis infused beverages for the U.S. market?  Personally, not my cup of tea, not unique enough or disruptive enough compared to LABS and true pharmaceutical applications.   

Tilray Brands Closes Transaction Acquiring Eight Beer & Beverage Brands From Anheuser-Busch; Solidifies Leadership Position in U.S. Craft Beer Market

GlobeNewswireOct 2, 2023 7:00 AM EDT

[okgonow]

wonder what the 4.5$ mill conversion price is or will be????  nothing in the NR about that

[subaru1i]

If you read the press release as it is, no other mentions in it made, then I'm assuming the $4.5 M in stock was at the closing price of the day the out of court settlement was reached.   There was no mention made of any sell restrictions on the stock either or conversion price.   Personally, I think it a safe bet by LABS because I think all the recreational stocks will